Rezultaty - Venner, Christopher
- Rezultaty 1 - 20 Rezultaty od 23
- Idź do następnej strony
-
1
Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism od Huang, Yung-Hsing, Almowaled, Meaad, Li, Jing, Venner, Christopher, Sandhu, Irwindeep, Peters, Anthea, Lavasanifar, Afsaneh, Lai, Raymond
Wydane 2021Text -
2
Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma od Kriangkum, Jitra, Motz, Sarah N., Debes Marun, Carina S., Lafarge, Sandrine T., Gibson, Spencer B., Venner, Christopher P., Johnston, James B., Belch, Andrew R., Pilarski, Linda M.
Wydane 2013Text -
3
Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model od Huang, Yung-Hsing, Molavi, Ommoleila, Alshareef, Abdulraheem, Haque, Moinul, Wang, Qian, Chu, Michael P., Venner, Christopher P., Sandhu, Irwindeep, Peters, Anthea C., Lavasanifar, Afsaneh, Lai, Raymond
Wydane 2018Text -
4
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis od Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane 2015Text -
5
Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome od Venner, Christopher P., Woltosz, Joanna Wegrzyn, Nevill, Thomas J., Deeg, H. Joachim, Caceres, Gisela, Platzbecker, Uwe, Scott, Bart L., Sokol, Lubomir, Sung, Sandy, List, Alan F., Karsan, Aly
Wydane 2013Text -
6
Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis od Dungu, Jason, Whelan, Carol J, Gibbs, Simon D, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa
Wydane 2012Text -
7
Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Dat... od Watanabe, Sharon M., Faily, Viane, Mawani, Asifa, Huot, Ann, Tarumi, Yoko, Potapov, Alexei, Fassbender, Konrad, Fairchild, Alysa, Joy, Anil A., King, Karen M., Roa, Wilson, Venner, Christopher P., Baracos, Vickie E.
Wydane 2020Text -
8
Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting od Venner, Christopher P., Gillmore, Julian D., Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer H, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane 2014Text -
9
Systemic Amyloidosis in England: an epidemiological study od Pinney, Jennifer H, Smith, Colette J, Taube, Jessi B, Lachmann, Helen J, Venner, Christopher P, Gibbs, Simon D J, Dungu, Jason, Banypersad, Sanjay M, Wechalekar, Ashutosh D, Whelan, Carol J, Hawkins, Philip N, Gillmore, Julian D
Wydane 2013Text -
10
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III) od Jaccard, Arnaud, Comenzo, Raymond L., Hari, Parameswaran, Hawkins, Philip N., Roussel, Murielle, Morel, Pierre, Macro, Margaret, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Mohty, Dania, Mercie, Patrick, Decaux, Olivier, Gillmore, Julian, Lavergne, David, Bridoux, Frank, Wechalekar, Ashutosh D., Venner, Christopher P.
Wydane 2014Text -
11
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma od Bahlis, Nizar J., Sutherland, Heather, White, Darrell, Sebag, Michael, Lentzsch, Suzanne, Kotb, Rami, Venner, Christopher P., Gasparetto, Cristina, Del Col, Aldo, Neri, Paola, Reece, Donna, Kauffman, Michael, Shacham, Sharon, Unger, T. J., Jeha, Jacqueline, Saint-Martin, Jean-Richard, Shah, Jatin, Chen, Christine
Wydane 2018Text -
12
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database od McCurdy, Arleigh, Venner, Christopher P., Masih-Khan, Esther, Louzada, Martha, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Jimenez-Zepeda, Victor H., Kotb, Rami, Kardjadj, Moustafa, Mian, Hira, White, Darrell, Stakiw, Julie, Aslam, Muhammad, Reiman, Anthony, Gul, Engin, Reece, Donna
Wydane 2022Text -
13
The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database od Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.
Wydane 2020Text -
14
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome od Pinney, Jennifer H., Whelan, Carol J., Petrie, Aviva, Dungu, Jason, Banypersad, Sanjay M., Sattianayagam, Prayman, Wechalekar, Ashutosh, Gibbs, Simon D. J., Venner, Christopher P., Wassef, Nancy, McCarthy, Carolyn A., Gilbertson, Janet A., Rowczenio, Dorota, Hawkins, Philip N., Gillmore, Julian D., Lachmann, Helen J.
Wydane 2013Text -
15
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis od Mian, Hira, Eisfeld, Christine, Venner, Christopher P., Masih-Khan, Esther, Kardjadj, Moustafa, Jimenez-Zepeda, Victor H., Khandanpour, Cyrus, Lenz, Georg, McCurdy, Arleigh, Sebag, Michael, Song, Kevin, LeBlanc, Richard, White, Darrell, Stakiw, Julie, Reiman, Anthony, Louzada, Martha, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Wydane 2022Text -
16
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma od Facon, Thierry, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell J., Karlin, Lionel, Benboubker, Lotfi, Rigaudeau, Sophie, Rodon, Philippe, Voog, Eric, Yoon, Sung-Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Twumasi-Ankrah, Philip, Yung, Godwin, Rifkin, Robert M., Moreau, Philippe, Lonial, Sagar, Kumar, Shaji K., Richardson, Paul G., Rajkumar, S. Vincent
Wydane 2021Text -
17
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA od Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja
Wydane 2022Text -
18
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients od Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Baljevic, Muhamed, Lentzsch, Suzanne, Rossi, Adriana C., Kotb, Rami, White, Darrell, Bahlis, Nizar J., Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, Ammu, Sonia, Ben-Shahar, Osnat, DeCastro, Andrew, Van Domelen, Dane, Zhou, Tianjun, Zhang, Chris, Bentur, Ohad S., Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea
Wydane 2021Text -
19
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group od Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean-Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P., Voorhees, Peter M., Wechalekar, Ashutosh D., Weiss, Brendan M., Nasr, Samih H.
Wydane 2018Text -
20
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study od Royal, Virginie, Leung, Nelson, Troyanov, Stéphan, Nasr, Samih H., Écotière, Laure, LeBlanc, Richard, Adam, Benjamin A., Angioi, Andrea, Alexander, Mariam P., Asunis, Anna Maria, Barreca, Antonella, Bianco, Paola, Cohen, Camille, Drosou, Maria E., Fatima, Huma, Fenoglio, Roberta, Gougeon, François, Goujon, Jean-Michel, Herrera, Guillermo A., Knebelmann, Bertrand, Lepori, Nicola, Maletta, Francesca, Manso, Rita, Motwani, Shveta S., Pani, Antonello, Rabant, Marion, Rennke, Helmut G., Rocatello, Dario, Rosenblum, Frida, Sanders, Paul W., Santos, Afonso, Soto, Karina, Sis, Banu, Touchard, Guy, Venner, Christopher P., Bridoux, Frank
Wydane 2020Text